Rangaramanujam M Kannan

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 22

Top Venues

Biomacromolecules

Bioengineering & translational medicine

Communications biology

Science translational medicine

Johns Hopkins University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins University

United States

Professor :: Ophthalmology

Publications

Joshua E Porterfield, Rishi Sharma, Ambar Scarlet Jimenez, Nirnath Sah, Sean McCracken, Lucia Zhang, Hyoung-Tae An, Seulki Lee, Sujatha Kannan, Anjali Sharma, Rangaramanujam M Kannan
Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure. Bioengineering & translational medicine 8 (3) (2023)
Joshua E Porterfield, Rishi Sharma, Ambar Scarlet Jimenez, Nirnath Sah, Sean McCracken, Lucia Zhang, Hyoung-Tae An, Seulki Lee, Sujatha Kannan, Anjali Sharma, Rangaramanujam M Kannan
Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure. Bioengineering & translational medicine 8 (3) (2023)
Ian Pitha, Siva Kambhampati, Anjali Sharma, Rishi Sharma, Liam McCrea, Ann Mozzer, Rangaramanujam M Kannan
Targeted Microglial Attenuation through Dendrimer-Drug Conjugates Improves Glaucoma Neuroprotection. Biomacromolecules 24 (3) (2023)
Joshua E Porterfield, Rishi Sharma, Ambar Scarlet Jimenez, Nirnath Sah, Sean McCracken, Lucia Zhang, Hyoung-Tae An, Seulki Lee, Sujatha Kannan, Anjali Sharma, Rangaramanujam M Kannan
Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure. Bioengineering & translational medicine 8 (3) (2023)
Kevin Emmerich, David T White, Siva P Kambhampati, Grace L Casado, Tian-Ming Fu, Zeeshaan Chunawala, Arpan Sahoo, Saumya Nimmagadda, Nimisha Krishnan, Meera T Saxena, Steven L Walker, Eric Betzig, Rangaramanujam M Kannan, Jeff S Mumm
Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina. Communications biology 6 (1) (2023)
Ian Pitha, Siva Kambhampati, Anjali Sharma, Rishi Sharma, Liam McCrea, Ann Mozzer, Rangaramanujam M Kannan
Targeted Microglial Attenuation through Dendrimer-Drug Conjugates Improves Glaucoma Neuroprotection. Biomacromolecules 24 (3) (2023)
Ian Pitha, Siva Kambhampati, Anjali Sharma, Rishi Sharma, Liam McCrea, Ann Mozzer, Rangaramanujam M Kannan
Targeted Microglial Attenuation through Dendrimer-Drug Conjugates Improves Glaucoma Neuroprotection. Biomacromolecules 24 (3) (2023)
Ian Pitha, Siva Kambhampati, Anjali Sharma, Rishi Sharma, Liam McCrea, Ann Mozzer, Rangaramanujam M Kannan
Targeted Microglial Attenuation through Dendrimer-Drug Conjugates Improves Glaucoma Neuroprotection. Biomacromolecules (2023)
Kevin Emmerich, David T White, Siva P Kambhampati, Grace L Casado, Tian-Ming Fu, Zeeshaan Chunawala, Arpan Sahoo, Saumya Nimmagadda, Nimisha Krishnan, Meera T Saxena, Steven L Walker, Eric Betzig, Rangaramanujam M Kannan, Jeff S Mumm
Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina. Communications biology 6 (1) (2023)
Kevin Emmerich, David T White, Siva P Kambhampati, Grace L Casado, Tian-Ming Fu, Zeeshaan Chunawala, Arpan Sahoo, Saumya Nimmagadda, Nimisha Krishnan, Meera T Saxena, Steven L Walker, Eric Betzig, Rangaramanujam M Kannan, Jeff S Mumm
Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina. Communications biology 6 (1) (2023)
Aaron M Gusdon, Nauder Faraday, John S Aita, Sunil Kumar, Ishan Mehta, HuiMahn A Choi, Jeffery L Cleland, Keith Robinson, Louise D McCullough, Derek K Ng, Rangaramanujam M Kannan, Sujatha Kannan
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Science translational medicine 14 (654) (2022)
Wathsala Liyanage, Tony Wu, Sujatha Kannan, Rangaramanujam M Kannan
Dendrimer-siRNA Conjugates for Targeted Intracellular Delivery in Glioblastoma Animal Models. ACS applied materials & interfaces 14 (41) (2022)
Louis DeRidder, Anjali Sharma, Kevin Liaw, Rishi Sharma, John John, Sujatha Kannan, Rangaramanujam M Kannan
Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis. Nanoscale 13 (2) (2021)
Hiren R Modi, Qihong Wang, Sarah J Olmstead, Elizabeth S Khoury, Nirnath Sah, Yu Guo, Payam Gharibani, Rishi Sharma, Rangaramanujam M Kannan, Sujatha Kannan, Nitish V Thakor
Systemic administration of dendrimer N-acetyl cysteine improves outcomes and survival following cardiac arrest. Bioengineering & translational medicine 7 (1) (2021)
Rishi Sharma, Joshua E Porterfield, Hyoung-Tae An, Ambar Scarlet Jimenez, Seulki Lee, Sujatha Kannan, Anjali Sharma, Rangaramanujam M Kannan
Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. Biomacromolecules 22 (8) (2021)
Michael A Harris, Huihui Kuang, Zachary Schneiderman, Maple L Shiao, Andrew T Crane, Matthew R Chrostek, Alexandru-Flaviu Tăbăran, Thomas Pengo, Kevin Liaw, Beibei Xu, Lucy Lin, Clark C Chen, M Gerard O'Sullivan, Rangaramanujam M Kannan, Walter C Low, Efrosini Kokkoli
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival. Science advances 7 (49) (2021)
Anjali Sharma, Kevin Liaw, Rishi Sharma, Ajit G Thomas, Barbara S Slusher, Sujatha Kannan, Rangaramanujam M Kannan
Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma. Biomacromolecules 21 (9) (2020)
Kevin Liaw, Fan Zhang, Antonella Mangraviti, Sujatha Kannan, Betty Tyler, Rangaramanujam M Kannan
Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioengineering & translational medicine 5 (2) (2020)
Kevin Liaw, Rajsekhar Reddy, Anjali Sharma, Jiangyu Li, Michelle Chang, Rishi Sharma, Sebastian Salazar, Sujatha Kannan, Rangaramanujam M Kannan
Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma. Bioengineering & translational medicine 6 (2) (2020)
Anjali Sharma, Kevin Liaw, Rishi Sharma, Talis Spriggs, Santiago Appiani La Rosa, Sujatha Kannan, Rangaramanujam M Kannan
Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma. Biomacromolecules 21 (12) (2020)
Diego F Nino, Qinjie Zhou, Yukihiro Yamaguchi, Laura Y Martin, Sanxia Wang, William B Fulton, Hongpeng Jia, Peng Lu, Thomas Prindle, Fan Zhang, Joshua Crawford, Zhipeng Hou, Susumu Mori, Liam L Chen, Andrew Guajardo, Ali Fatemi, Mikhail V Pletnikov, Rangaramanujam M Kannan, Sujatha Kannan, Chhinder P Sodhi, David J Hackam
Cognitive impairments induced by necrotizing enterocolitis can be prevented by inhibiting microglial activation in mouse brain. Science translational medicine 10 (471) (2019)
Rishi Sharma, Soo-Young Kim, Anjali Sharma, Zhi Zhang, Siva Pramodh Kambhampati, Sujatha Kannan, Rangaramanujam M Kannan
Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation. Bioconjugate chemistry 28 (11) (2017)

Rangaramanujam M Kannan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rangaramanujam M Kannan